Healthstream (HSTM) Cash & Equivalents (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash & Equivalents data on file, last reported at $48.7 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $48.7 million, down 36.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.7 million (down 36.98% YoY), and the FY2025 annual result was $36.2 million, down 39.19% from the prior year.
• Cash & Equivalents grew to $48.7 million in Q1 2026 per HSTM's latest filing, from $36.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $77.3 million in Q1 2025 and troughed at $25.8 million in Q2 2023.
• A 5-year average of $48.1 million and a median of $48.3 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 78.77% in 2024, then sank 39.19% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $46.0 million in 2022, then declined by 12.36% to $40.3 million in 2023, then surged by 47.45% to $59.5 million in 2024, then slumped by 39.19% to $36.2 million in 2025, then soared by 34.71% to $48.7 million in 2026.
• Business Quant data shows HSTM's Cash & Equivalents at $48.7 million in Q1 2026, $36.2 million in Q4 2025, and $53.5 million in Q3 2025.